
Biotechnology • Pharmaceuticals • Healthcare Insurance
Travere Therapeutics is a biopharmaceutical company committed to identifying, developing, and delivering life-changing therapies for people living with rare diseases, particularly those related to rare kidney and metabolic disorders. The company has a strong focus on advancing science in these fields, with a pipeline that includes treatments for conditions such as IgA nephropathy and focal segmental glomerulosclerosis. With the full U. S. FDA approval of its non-immunosuppressive treatment for IgA nephropathy, Travere Therapeutics continues to set new standards of care. The company collaborates with the rare kidney disease community, including patient advocacy organizations and clinical trial investigators, to bring hope to patients with these serious conditions.
201 - 500 employees
Founded 2013
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
October 23
Senior Manager analyzing commercial analytics as part of a biopharmaceutical team. Applying statistical techniques and leading data-driven recommendations for decision-making.
October 7
Associate Director driving digital transformation and operational excellence in Medical Affairs at Travere Therapeutics. Leading digital initiatives and coordinating cross-functional teams to enhance patient engagement.